Anika Therapeutics, Inc. Announces Resignation of Sylvia Cheung as Treasurer and Assistant Secretary Effective August 21, 2020
June 03, 2020 at 01:37 am IST
Share
Anika Therapeutics, Inc. announced that on May 27, 2020, Sylvia Cheung notified the company that she was resigning from her position of Treasurer and Assistant Secretary effective August 21, 2020 for personal reasons. The company has initiated a search process to identify a new chief financial officer and has engaged an executive search firm to assist in the search.
Anika Therapeutics, Inc. is a joint preservation company focused on developing, manufacturing, and commercializing products based on hyaluronic acid (HA) technology platform. The OA Pain Management product family consists of Monovisc and Orthovisc that provides pain relief from osteoarthritis conditions and Cingal consisting of its cross-linked HA material combined with a fast-acting steroid. Its Joint Preservation and Restoration product family consists of its portfolio of orthopedic regenerative solutions products: Integrity, Tactoset, and Hyalofast; its line of sports medicine solutions repairs and reconstructs damaged ligaments and tendons, and its Arthrosurface portfolio of bone preserving joint technologies, including partial joint replacement, joint resurfacing, and minimally invasive and bone sparing implants. Its Non-Orthopedic product family provides orthopedic applications, including adhesion barrier product, advanced wound care products, and ear, nose and throat products.
ANIKA THERAPEUTICS, INC. 
